Literature DB >> 18463409

Racial/ethnic disparities in liver transplant surgery and hospice use: parallels, differences, and unanswered questions.

Alexander K Smith1, Daniela Ladner, Ellen P McCarthy.   

Abstract

Despite well-documented racial/ethnic disparities in liver transplantation and hospice enrollment, reasons for these disparities are unclear. This study was conducted to elucidate what is known and unknown about the underlying causes of racial/ethnic disparities in liver transplantation and hospice enrollment. The root causes of inequities in access to liver transplantation and hospice are as yet poorly understood. Potential contributors to differences include differences in preferences, mistrust of the health care system, geographic factors such as neighborhood, health care system factors such as access to care and managed care versus fee-for-service insurance status, and social factors such as the availability of a full time caregiver. Although the goals of care are different, by examining hospice and transplant surgery side by side in the larger context of health disparities, a number of potentially promising avenues for future research have been uncovered.

Mesh:

Year:  2008        PMID: 18463409     DOI: 10.1177/1049909108315914

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  4 in total

1.  Disparities in access to basic laparoscopic surgery at U.S. academic medical centers.

Authors:  J Esteban Varela; Ninh T Nguyen
Journal:  Surg Endosc       Date:  2010-09-17       Impact factor: 4.584

2.  Liver transplantation trends in the HIV population.

Authors:  Nyingi M Kemmer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2011-08-30       Impact factor: 3.199

3.  Variation in access to the liver transplant waiting list in the United States.

Authors:  Amit K Mathur; Valarie B Ashby; Douglas S Fuller; Min Zhang; Robert M Merion; Alan Leichtman; John Kalbfleisch
Journal:  Transplantation       Date:  2014-07-15       Impact factor: 4.939

4.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.